Narrow search
Showing 1 - 10 of 10,222
Cover Image
Socio-economic significance and characteristic features of pharmacy
Tischenko Aleksandr N.; Dorovsky Oleksandr V. - In: The Problems of Economy (2013) 3, pp. 13-20
The article considers main factors indicative of significance of the world pharmaceutical industry in the global economy. It shows the total volume of the world pharmaceutical market and regional structure of the world pharmaceutical production. It marks out the leading role of pharmacy in the...
Persistent link: https://www.econbiz.de/10010855971
Cover Image
СОЦИАЛЬНО-ЭКОНОМИЧЕСКОЕ ЗНАЧЕНИЕ И ХАРАКТЕРНЫЕ ЧЕРТЫ ФАРМАЦИИ
НИКОЛАЕВИЧ, ТИЩЕНКО АЛЕКСАНДР; … - In: Проблемы экономики (2013) 3, pp. 13-20
В статье рассмотрены основные факторы, свидетельствующие о значении мировой фармацевтической отрасли в глобальной экономике. Показаны общий объем мирового...
Persistent link: https://www.econbiz.de/10011226478
Cover Image
Rationalisierung und Wettbewerb im Arzneimittelmarkt
Herr, Annika - Düsseldorf Institute for Competition Economics (DICE), … - 2012
verschiedene deutsche Regulierungsansätze zur Stärkung des Wettbewerbs und der Effizienz im Arzneimittelmarkt beschrieben und …
Persistent link: https://www.econbiz.de/10010980407
Cover Image
РЕГУЛИРОВАНИЕ ФАРМАЦЕВТИЧЕСКОГО РЫНКА: СУЩЕСТВУЕТ ЛИ ПОЧВА ДЛЯ РАЗВИТИЯ ИННОВАЦИОННЫХ ФАРМАЦЕВТИЧЕСКИХ ПРЕПАРАТОВ В РОССИИ?...
АРТЁМ, ХОНЛ ТОМ - In: Проблемы учета и финансов (2012) 3, pp. 73-75
Власть Российской Федерации имеет цель к 2020 г. создать мощную фармацевтическую отрасль, которая будет способна производить инновационные препараты. Автор...
Persistent link: https://www.econbiz.de/10011230870
Cover Image
Pharmaceutical industry, drug quality and regulation. Evidence from US and Italy
Atella, Vincenzo; Bhattacharya, Jay; Carbonari, Lorenzo - Centro di Studi Internazionali Sull'Economia e la … - 2008
regime than in the PC regime or a in combination of the two. Second, PC regulation reduces the difference in terms of high …
Persistent link: https://www.econbiz.de/10005694983
Cover Image
Regulating Pharmaceutical Prices in the European Union
Csizmazia, Roland Attila - Volkswirtschaftliche Fakultät, … - 2013
This case study aims to provide a better understanding of the necessity for regulation in the market for …
Persistent link: https://www.econbiz.de/10011108441
Cover Image
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan; Mahlich, Jörg - In: Health Economics Review 4 (2014) 1, pp. 1-9
The results can be interpreted as further evidence of the deteriorating effect of regulation on firm’s incentives to …
Persistent link: https://www.econbiz.de/10010998792
Cover Image
Regulatory Europeanization, National Autonomy and Regulatory Effectiveness: Marketing Authorization for Pharmaceuticals
Feick, Juergen - Max Planck Institute for the Study of Societies - 2002
AbstractThe EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it achieved … regulatory costs to industry. There is little evidence that the public's health is less well protected when regulation is …
Persistent link: https://www.econbiz.de/10005236980
Cover Image
Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU
Danzon, Patricia - In: International Journal of the Economics of Business 4 (1997) 3, pp. 301-322
differentials between countries are being undermined by parallel trade and regulation based on foreign prices. This break down of …
Persistent link: https://www.econbiz.de/10009213567
Cover Image
What if there was a stronger pharmaceutical price competition in Spain? When regulation has a similar effect to collusion
Moreno-Torres, Ivan - Xarxa de Referència en Economia Aplicada (XREAP) - 2011
monthly data for pharmaceuticals prescribed from 1997 to 2005. The simulation indicates that the regulation of prices is … shares of both manufacturers and active ingredients, and a reversal of generic drugs. Therefore, pro-competitive regulation …
Persistent link: https://www.econbiz.de/10010614910